PharmaBoardroom

Myriem Tamimy – Country Manager Morocco, Tunisia &…

Myriem Tamimy gives an overview of the ongoing situation for Janssen and pharma multinationals more generally in Morocco, discusses the next steps in…

Glenn Vaughan – Advisor, British Chamber of Commerce | EU…

Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare…

Christian Schuhmacher – CEO, King’s College Hospital UAE

One year after King’s College Hospital’s establishment in the UAE, CEO Christian Schuhmacher discusses the hospital’s unique approach of…

Romuald Gaudefroy – Managing Director, CAF-DCF, Belgium

Romuald Gaudefroy, managing director of CAF-DCF, the Belgian subsidiary of the LFB Group, introduces the company which was integrated into LFB in…

Ousama Al Haj – Director UAE, Bahrain, Oman & Qatar…

Ousama Al Haj, director for UAE, Bahrain, Oman & Qatar at AstraZeneca, highlights the company’s substantial growth and favourable position in…

Brain Drain: A Ticking Time Bomb for Romanian Healthcare

According to a 2015 United Nations International Migration Report, since Romania joined the European Union in 2007, around 3.4 million Romanians have…

Romania: Europe’s Most Challenging Market for Generics?

While the dismal regulatory environment in Romania has negatively affected the innovators with the uncertain and lengthy regulatory approval timelines…

5 Cell & Gene Companies to Watch in South Korea

South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Jingsong Wang – Chairman & CEO, Harbour BioMed, China

PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

China’s Regulatory Reform and its Contribution to Global…

Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) highlights the leaps and bounds with which…

Top 10 Pharma Companies in Mexico

Here we highlight the top 10 pharma companies in Mexico based on IQVIA data from February MAT 2020. Four of the top ten companies are Mexican: PISA,…

“Drug” Companies are Missing Their Moment to Write a New…

John G. Singer examines how the ongoing coronavirus pandemic may create a new dichotomy for global healthcare - and why pharma companies still wedded…

Tagged with A